| How to build and interpret a nomogram for cancer prognosis A Iasonos, D Schrag, GV Raj, KS Panageas Journal of clinical oncology 26 (8), 1364-1370, 2008 | 2537 | 2008 |
| T-cell invigoration to tumour burden ratio associated with anti-PD-1 response AC Huang, MA Postow, RJ Orlowski, R Mick, B Bengsch, S Manne, W Xu, ... Nature 545 (7652), 60-65, 2017 | 1484 | 2017 |
| Immune-related adverse events, need for systemic immunosuppression, and effects on survival and time to treatment failure in patients with melanoma treated with ipilimumab at … TZ Horvat, NG Adel, TO Dang, P Momtaz, MA Postow, MK Callahan, ... Journal of Clinical Oncology 33 (28), 3193, 2015 | 1085 | 2015 |
| KIT as a therapeutic target in metastatic melanoma RD Carvajal, CR Antonescu, JD Wolchok, PB Chapman, RA Roman, ... Jama 305 (22), 2327-2334, 2011 | 1011 | 2011 |
| Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma PB Chapman, LH Einhorn, ML Meyers, S Saxman, AN Destro, ... Journal of Clinical Oncology 17 (9), 2745-2745, 1999 | 991 | 1999 |
| Weekly Trastuzumab and Paclitaxel Therapy for Metastatic Breast Cancer With Analysis of Efficacy by HER2 Immunophenotype and Gene Amplification AD Seidman, MN Fornier, FJ Esteva, L Tan, S Kaptain, A Bach, ... Journal of Clinical Oncology 19 (10), 2587-2595, 2001 | 755 | 2001 |
| Developing a cancer‐specific geriatric assessment: A feasibility study A Hurria, S Gupta, M Zauderer, EL Zuckerman, HJ Cohen, H Muss, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 665 | 2005 |
| Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model LE Abrey, L Ben-Porat, KS Panageas, J Yahalom, B Berkey, W Curran, ... Journal of Clinical Oncology 24 (36), 5711-5715, 2006 | 634 | 2006 |
| Risk of arterial thromboembolism in patients with cancer BB Navi, AS Reiner, H Kamel, C Iadecola, PM Okin, MSV Elkind, ... Journal of the American College of Cardiology 70 (8), 926-938, 2017 | 545 | 2017 |
| Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival GY Ku, J Yuan, DB Page, SEA Schroeder, KS Panageas, RD Carvajal, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 492 | 2010 |
| Leptomeningeal metastases in the MRI era JL Clarke, HR Perez, LM Jacks, KS Panageas, LM Deangelis Neurology 74 (18), 1449-1454, 2010 | 457 | 2010 |
| Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial RD Carvajal, JA Sosman, JF Quevedo, MM Milhem, AM Joshua, ... Jama 311 (23), 2397-2405, 2014 | 453 | 2014 |
| Stroke in patients with cancer: incidence and etiology DM Cestari, DM Weine, KS Panageas, AZ Segal, LM DeAngelis neurology 62 (11), 2025-2030, 2004 | 451 | 2004 |
| Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid JH Park, B Qiao, KS Panageas, MJ Schymura, JG Jurcic, TL Rosenblat, ... Blood, The Journal of the American Society of Hematology 118 (5), 1248-1254, 2011 | 427 | 2011 |
| Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection D Schrag, KS Panageas, E Riedel, LD Cramer, JG Guillem, PB Bach, ... Annals of surgery 236 (5), 583-592, 2002 | 403 | 2002 |
| Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab J Yuan, M Adamow, BA Ginsberg, TS Rasalan, E Ritter, HF Gallardo, Y Xu, ... Proceedings of the National Academy of Sciences 108 (40), 16723-16728, 2011 | 396 | 2011 |
| Variates of survival in metastatic uveal melanoma P Rietschel, KS Panageas, C Hanlon, A Patel, DH Abramson, ... Journal of Clinical Oncology 23 (31), 8076-8080, 2005 | 364 | 2005 |
| Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma RC Taylor, A Patel, KS Panageas, KJ Busam, MS Brady Journal of Clinical Oncology 25 (7), 869-875, 2007 | 361 | 2007 |
| Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid EI Pentsova, RH Shah, J Tang, A Boire, D You, S Briggs, A Omuro, X Lin, ... Journal of clinical oncology 34 (20), 2404, 2016 | 359 | 2016 |
| Ibrutinib unmasks critical role of Bruton tyrosine kinase in primary CNS lymphoma C Grommes, A Pastore, N Palaskas, SS Tang, C Campos, D Schartz, ... Cancer discovery 7 (9), 1018-1029, 2017 | 353 | 2017 |
